Since his second term started, President Trump has introduced a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry.

White House model estimates on cost savings from most-favored nation drug prices are speculative and depend on a set of ...

Chris Spear and the ATA welcome an FDA rule change that targets drug test "cheating" by implementing oral fluid and hair ...

In the latest episode of IPWatchdog Unleashed, I spoke with Brent Bellows about the policy and business realities of ...

Minnesota's Legislature is reckoning with 340B, a prescription medication discount program for nonprofit hospitals, for ...

Some industry-funded clinical trials show signs of being designed to market drugs rather than to test them for their safety ...

But if your drug cocktail looks anything like the infamous looksmaxxers infesting a certain corner of the internet, you may ...

Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...

On April 15, 2026, the European Data Protection Board ("EDPB") adopted Guidelines 1/2026 on the processing of personal data for scientific ...

The powerful synthetic opioid cychlorphine, first flagged by a DEA lab in 2024, has since been observed in cases across at ...

With President Donald Trump recently signing an executive order to accelerate research and ease the restrictions on ...

Donovan: Pfizer CentreOne’s oral solid dose network is built around three strategically positioned manufacturing sites: ...